One of the genes that met these criteria was DACH1. Microarray data from a previous study by our group [3] had indicated that its expression is also upregulated in most colorectal cancers, although significantly reduced mRNA levels were observed in some of the cancers tested, all of which were MMR-deficient (Figure 4). This evidence concerns the gene DACH1 and cancer.